News Coverage 12.06.20 Share on Twitter Share on Facebook Share on LinkedIn Biomarker predicts poor response to CAR-T, points way to personalized, gene-edited therapy Related Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science